Policy & Regulation
14 May 2021 - - US-based biopharma company Osmol Therapeutics has initiated Investigational New Drug enabling studies to develop a therapy to prevent chemotherapy-induced peripheral neuropathy, the co...
14 May 2021 - - US-based precision medicine company Gemini Therapeutics, Inc. (NASDAQ: GMTX) has completed enrollment in its Phase 2a trial advancing GEM103 as a potential add-on therapy for patients ...
14 May 2021 - - US-based cannabinoid-based therapies developer India Globalization Capital, Inc. (NYSE American: IGC) it has completed Cohort 1 of its Phase 1 clinical trial testing IGC's tetrahy...
14 May 2021 - - US-based biotechnology company Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) has appointed Alison L. Hannah, M.D. to its board of directors, the company said.

Rigel...
14 May 2021 - Antengene Corporation Limited (SEHK: 6996.HK), a China-based biopharmaceutical company, has received approval from China's National Medical Products Administration (NMPA) for the st...
14 May 2021 - Japan-based Astellas Pharma Inc (TSE: 4503) announced on Thursday that Japan's Ministry of Health, Labour and Welfare has given priority review for the firm's New Drug Applicat...
Related Headlines